...
ARDTSMALL

Ardent Health Partners, LLC

HealthcareMedical - Care Facilities
$9.39
$0.00(-0.95%)
52W$8.07
$15.55
FinancialsValuationvs HCA
Updated Mar 1, 12:00 AM
RSI56
RS Rating25/99
Beta0.88
Volatility54%
F-Score8/9
Mkt Cap$1.3B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Ardent Health Partners, LLC is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 25), showing significant lag compared to the market leaders. Earnings contraction of 189% provides fundamental context to the price action. Investors should exercise caution due to high volatility (54% annualized), which requires wider risk management.

Relative Strength
25
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.88
vs S&P 500
DEFENSIVE
52W Position
18%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$8.95
50 SMA > 100 SMA$10.43
100 SMA > 150 SMA$11.14
150 SMA > 200 SMA$11.74

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.21+1.94%ABOVE
50 SMA$8.95+4.96%ABOVE
100 SMA$10.43-9.98%BELOW
150 SMA$11.14-15.70%BELOW
200 SMA$11.74-20.04%BELOW

Price Performance

1D-0.9%
1W-3.3%
1M+13.8%
3M+6.9%
6M-25.1%
YTD+8.7%
1Y-35.9%
3Y-16.4%
52-Week Trading Range18% from low
$9.39
52W Low$8.07
52W High$15.55

Technical Indicators

RSI (14)NEUTRAL
55.7
305070
VCP ScoreCOOL
6/10
Base depth: 20.1%

Risk Profile

Beta
0.88
52W Vol
54%
ATR
$0.33
Max DD (1Y)
-47%

Volume Analysis

Today
9
50D Avg
341.2K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+1675%
$0.86
Q1'25+53%
$0.29
Q2'25+73%
$0.52
Q3'25-189%
$-0.17
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:+23.16%
3 Years:+12.75%
TTM:+10.86%

Compounded Profit Growth

10 Years:—
5 Years:+73.67%
3 Years:—
TTM:+139.85%

Stock Price CAGR

10 Years:-5.23%
5 Years:-10.18%
3 Years:-16.38%
1 Year:-35.95%

Return on Equity

10Y Avg:3.4%
5Y Avg:3.3%
3Y Avg:14.1%
Last Year:12.6%

Key Metrics

Market Cap$1.3B
Gross Margin82.7%
Net Margin3.5%
Piotroski F-Score8/9

More ARDT Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ARDT vs HCAHCATHCMPWACHC

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 25 meansARDT outperformed 25% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.88 means 12% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 8/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is ARDT in an uptrend right now?

ARDT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is ARDT overbought or oversold?

ARDT's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is ARDT outperforming the market?

ARDT has a Relative Strength (RS) Rating of 25 out of 99. ARDT is currently lagging the broader market.

Where is ARDT in its 52-week range?

ARDT is trading at $9.39, which is 60% of its 52-week high ($15.55) and 18% above its 52-week low ($8.07).

How volatile is ARDT?

ARDT has a Beta of 0.88 and 52-week volatility of 54%. It's less volatile than the S&P 500 - generally more stable.